the aid library

LIST OPTIONS

Filter

7472

WHO's response to the Ukraine crisis

World Health Organisation (WHO) (2023) C_WHO

Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ... more

External Link

Human Rights based research into COVID-19 related violations with focus on persons with disabilities

Malawi Human Rights Commission (2021) CC

The goal of the study was to assess the feasibility of the COVID-19 measures and their resultant impact on Persons with Disabilities in Malawi. Specifically, the study addressed the following objectives: a) To evaluate Government’s response to COVID-19 following the adoption of the new measures... more

Download (214)

View PDF (221)

Human African trypanosomiasis. Seminar

Büscher P., Cecchi G., Jamonneau V. et al (2017) C2

The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017. Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to ... more

Download (259)

View PDF (239)

Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2021 global survey

World Health Organisation (WHO) (2023) C_WHO

To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ... more

External Link

Comprehensive COVID-19 Slideset: Symptoms and Clinical Manifestations

Clinical Care Options (2021) CC

26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.

Download (3855)

View PDF (3265)

Standard Treatment Guidelines. Nigeria

Federal Ministry of Health Nigeria , World Health Organisation (WHO) (2008) C_WHO

Download (6517)

View PDF (2856)

WHO Monographs On Selected Medicinal Plants - Volume 4
recommended

World Health Organization WHO (2009) C_WHO

• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States; • provide models to assist Member States in developing their own mono- graphs or formularies for these... more

Download (131)

View PDF (136)

National Tuberculosis and Leprosy Control Strategic Plan

Government of Malawi; Ministry of Health Malawi (2024) CC2

Malawi is a landlocked country with a surface area of 118,484 km2. Administratively, the country is divided into three regions, namely the Northern, Central and Southern regions. The country has 28 districts, which are further divided into traditional authorities (TA) ruled by chiefs. The TAs are su... more

Download (112)

View PDF (95)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (147)

View PDF (82)

Métodos de diagnóstico para a doença de Chagas: uma atualização

Ferreira Alves, D.; et al. (2018) CC

Diagnostic methods of Chagas disease: an update. RBAC. 2018;50(4):330-3

Download (336)

View PDF (248)

WHO manual for HIV drug resistance testing using dried blood spot specimens

World Health Organization WHO (2020) C_WHO

HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ... more

Download (407)

View PDF (228)

Document de référence en RÉANIMATION à l'usage des Commissions de Qualification

Ordre National des Médecins (2017) CC

La réanimation a pour objectifs de prévenir et de pallier les différentes défaillances viscérales aiguës. Elle s’adresse aux malades graves et est actuellement considérée comme un élément normal de l’arsenal thérapeutique. Les médecins et les soignants ont démontré l’utilité ... more

Download (2150)

View PDF (1965)

Birth defects surveillance: a manual for programme managers

World Health Organization (2014)

Download (256)

View PDF (260)

The compound impact of extreme weather events and COVID-19

Walton D., Arrighi J., et al. IFRC - International Federation of Red Cross (2021) C2

From the start of the COVID-19 pandemic until August 2021, extreme weather events have affected at least 139.2 million people and killed at least 17,242 people in at least 433 unique events. These figures are certainly an underestimate, as they do not include estimates of numbers of people affected ... more

Download (251)

View PDF (294)

Encopresis - spanish

A. von Gontard IACAPAP (2017) C2

Transtornos del desarrollo Capítulo C.5 Edición en español Editor: Nieves Hermosín Carpio Traducción: María Carballo Novoa, María Esteban Arenós

Download (523)

View PDF (855)

National Guidelines for the Use of Antiretroviral Therapy in Adults and Adolescents

National Center for HIVAIDS, Dermatology and STD, Cambodia Ministry of Health (2012) CC

Download (576)

View PDF (790)

Guidelines for antiretroviral therapy in Ghana

Ghana AIDS Commission (2010) C1

Download (123)

View PDF (154)

COVID-19 and Food Safety: Guidance for Food Businesses

World Health Organization WHO (2020) C_WHO

Download (343)

View PDF (502)

Recommendacónes para o manejo da coinfeccáo TB-HIV em servicos de actencáo especializada a pessoas vivendo com HIV/AIDS

Ministério da saúde; TB HIV; Junitos pelo fin da Tuberculose (2013) C2

Download (443)

View PDF (399)

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended

World Health Organization WHO (2021) C_WHO

Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident... more

WHO Monographs On Selected Medicinal Plants - Volume 4 recommended

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 recommended

WHO Monographs On Selected Medicinal Plants - Volume 4
recommended

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended